Install
Daily news and insights on the fast-growing longevity market – antiaging, biotech, research, investment, supplements and rejuvenation therapies. First Longevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest. First Longevity Limited does
- 60articles · 30d
- 3+ day agolatest article
- Aug 15, 2026earliest in window
- 95%with images
- 332avg words
- Medical 51
- Health & Wellness 47
- Health 28
- Science & Technology 26
- Science & Nature 8
- Business & Industrial 7
- Economy, Business & Finance 5
- Beauty & Fitness 3
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Manila’s biggest aesthetics empire makes a move on longevity
3+ day, 16+ hour ago (194+ words) I’ve lived in the Philippines long enough to know exactly what the Belo name means here. For nearly three decades, it has been shorthand for one thing: looking good, whatever it takes. So when I heard that Belo Medical Group…...
Moonwalk raises $70m for adipose-targeted RNAi
4+ day, 15+ hour ago (466+ words) Moonwalk CEO and cofounder Alex Aravanis told Longevity.Technology that the company believes its preclinical body-composition findings arise from acting directly on adipose rather than indirectly through appetite. “Our approach is fundamentally different because MW101 is designed to act directly on…...
Neko Health body scan lands in NYC with 25K on the waitlist
4+ day, 15+ hour ago (303+ words) There’s a line that Neko Health likes to point to: 25,000 New Yorkers signed up before the company had even picked a paint color for its walls. It’s a waitlist number for a clinic that hadn’t opened yet, in a city…...
Lone Korean biotech nears $81m antiaging prize
5+ day, 16+ hour ago (365+ words) Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Technology examines the science behind each team’s approach, the trial data supporting it and what stands between them and the competition’s…...
Celularity lands $300m MuseCell manufacturing deal
6+ day, 17+ hour ago (344+ words) Deals in cell therapy tend to get announced in two flavors: the kind built around a single drug, and the kind built around infrastructure. This unglamorous plumbing decides whether any of these therapies can actually be made at scale. The…...
Longevity.Technology wants to make longevity make sense
6+ day, 18+ hour ago (186+ words) Longevity.Technology has launched Longevity Bites, a new segment running alongside its flagship podcast, Longevity.Technology UNLOCKED. The format is simple on paper: ten to fifteen minutes, one topic, explained properly. In practice, it’s the company’s answer to a gap…...
Will AI Make Death Optional? - Longevity.Technology UNLOCKED
6+ day, 20+ hour ago (241+ words) What would have to be true for AI to genuinely change the trajectory of human aging? The answer is more complicated than simply discovering an “anti-aging drug.” AI is already compressing parts of drug discovery, with one AI-designed candidate reaching…...
ImmunoBrain’s immune reset shows promise in Alzheimer’s
1+ week, 5+ day ago (250+ words) The underlying science traces back more than 25 years to work by Professor Michal Schwartz, ImmunoBrain’s scientific co-founder, whose research challenged the long-held assumption that the brain operates in isolation from the body’s immune defenses. As with the tau-targeting therapies emerging…...
Mount Sinai’s $1m XPRIZE bet: reset immune system, slow aging
2+ week, 5+ day ago (549+ words) Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Technology examines the science behind each team’s approach, the trial data supporting it and what stands between them and the competition’s…...
New Alzheimer’s contender Vandria clears key hurdle
2+ week, 6+ day ago (403+ words) Fresh data presented at the Alzheimer’s Association International Conference (AAIC) in London suggest that VNA-318 is behaving in humans much as researchers had hoped. One of the biggest reasons experimental Alzheimer’s drugs fail is that encouraging biology seen in laboratory…...